Open Beta
TREN
MetriLume
TREN

US marketsONC

SEC-sourced researchBeta

ONC

BeOne Medicines Ltd.

Company comparison ↗

Data passport

CIK
0001651308
Exchange
Nasdaq
Business activity
Pharmaceutical Preparations · SIC 2834
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 2,458,779,000.0000 USD; December 2024: 3,810,241,000.0000 USD; December 2025: 5,343,033,000.0000 USD5.3B USD0 USD0December 2023December 2024December 2025
ONC · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20232,458,779,000.0000Feb 26, 2026
December 20243,810,241,000.0000Feb 26, 2026
December 20255,343,033,000.0000Feb 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20255,343,033,000.0000286,933,000.00001,127,580,000.00008,188,573,000.00003,827,379,000.0000Feb 26, 2026
December 20243,810,241,000.0000-644,786,000.0000-140,631,000.00005,920,910,000.00002,588,688,000.0000Feb 26, 2026
December 20232,458,779,000.0000-881,708,000.0000-1,157,453,000.0000——Feb 26, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

79/100
Profitability61
Growth90
Balance sheet53
Cash generation92
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$5.34BJan 1, 2025 – Dec 31, 2025Feb 26, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$3.81BJan 1, 2024 – Dec 31, 2024Feb 26, 202610-K
Net incomeNetIncomeLoss$286.93MJan 1, 2025 – Dec 31, 2025Feb 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$1.13BJan 1, 2025 – Dec 31, 2025Feb 26, 202610-K
Total assetsAssets$8.19BDec 31, 2025Feb 26, 202610-K
Total liabilitiesLiabilities$3.83BDec 31, 2025Feb 26, 202610-K

New filings

Explore methodology ↗